IgGenix Announces Completion of Enrollment for Phase 1 Clinical Trial “ACCELERATE Peanut” with IGNX001 in Peanut Allergy

IgGenix Announces Completion of Enrollment for Phase 1 Clinical Trial “ACCELERATE Peanut” with IGNX001 in Peanut Allergy – NEWSnet – News… as it used to be